A Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment With Tigulixostat in Gout Patients With Hyperuricemia

Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting

Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials